The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety.
Saved in:
| Title: | The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety. |
|---|---|
| Authors: | Leonard, Charles E.1 (AUTHOR) celeonar@pennmedicine.upenn.edu, Brensinger, Colleen M.1 (AUTHOR), Dawwas, Ghadeer K.1 (AUTHOR), Deo, Rajat1,2 (AUTHOR), Bilker, Warren B.1 (AUTHOR), Soprano, Samantha E.1 (AUTHOR), Dhopeshwarkar, Neil1 (AUTHOR), Flory, James H.1,3 (AUTHOR), Bloomgarden, Zachary T.4 (AUTHOR), Gagne, Joshua J.5 (AUTHOR), Aquilante, Christina L.6 (AUTHOR), Kimmel, Stephen E.1,2 (AUTHOR), Hennessy, Sean1,7 (AUTHOR) |
| Source: | Cardiovascular Diabetology. 2/25/2020, Vol. 19 Issue 1, p1-11. 11p. 2 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
